Odonate Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $127,433,000.
Profit Margin
| 2015 | 0 | -158K | |
|---|---|---|---|
| 2016 | 0 | -3.08M | |
| 2017 | 0 | -32.74M | |
| 2018 | 0 | -88.96M | |
| 2019 | 0 | -111.82M | |
| 2020 | 0 | -126.35M |
ODT Income Statement (2015 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | ||||||
Research and development | 117.04M | 104.03M | 79.94M | 27.90M | 2.62M | 0 |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 127.43M | 114.93M | 90.76M | 32.74M | 3.08M | -158K |
Operating income | -127.43M | -114.93M | -90.76M | -32.74M | -3.08M | -158K |
Other income (expenses), net | 1.08M | 3.10M | 1.80M | 0 | 0 | 0 |
Income before tax | -126.35M | -111.82M | -88.96M | -32.74M | -3.08M | -158K |
Income tax expense | 1.08M | 3.10M | 1.80M | 0 | 0 | 0 |
Net income | -126.35M | -111.82M | -88.96M | -32.74M | -3.08M | -158K |
Earnings per share | ||||||
Basic EPS | -3.85 | -4.05 | -3.64 | -2.31 | -0.11 | -0.00 |
Diluted EPS | -3.85 | -4.05 | -3.64 | -2.31 | -0.11 | -0.00 |
| Data source | Data source | Data source | Data source |